Non-invasive biomarkers which identify different mechanisms of disease in subgroups of irritable bowel syndrome (IBS) could be valuable. Our aim was to seek useful magnetic resonance imaging (MRI) parameters that could distinguish each IBS subtypes. SUPPLEMENTARY MATERIAL is linked to the online version of the paper at
INTRODUCTION
Irritable bowel syndrome (IBS) is ubiquitous and yet our knowledge of the mechanisms underlying this condition remained limited. Treatment for IBS is unsatisfactory as it is based on patient history, which can be unreliable. Th us recording stool patterns by daily diary show most patients overestimate how abnormal their bowel patterns are ( 1 ) . Objective markers could be valuable if they allowed a categorization based on abnormalities of pathophysiology. Th e ideal would be non-invasive and patient acceptable. Th is unfortunately is not true of manometry and barostat studies while gamma scintigraphy and abdominal x-rays, although noninvasive, involve exposure to radiation, which would not be ideal in this cohort of patients as they comprise mostly young women. Th erefore, there is a need for objective measures of small bowel and colonic function in this group of patients to guide treatment.
Magnetic resonance imaging (MRI) has many advantages because of its ability to study the gastrointestinal physiology and its function without exposure to ionizing radiation. It has been used to noninvasively measure small ( 2 ) and large bowel ( 3 ) volumes both fasting and fed in health and IBS and also to directly visualize and measure colonic wall movements ( 4 ) . Previous studies showed distinctive abnormalities in IBS patients with diarrhea (IBS-D) with decreased small bowel water content (SBWC) ( 2 ) and an ascending colon (AC), which did not show the usual postprandial increase but instead showed an immediate increase in transverse colon (TC) volume suggesting failure of postprandial accommodation in the AC ( 3 ) . It is unclear whether this is a feature of all IBS or specifi cally to IBS-D. Th erefore, our aim in this study was to assess small bowel, colonic regional volumes and gut transit in subtypes of IBS to determine if there are distinct regional diff erences in the diff erent small intestine and colon of the three main subtypes of IBS.
METHODS
Th is was an open label study designed to compare the underlying pathophysiology of the small and large bowel in diff erent subtypes of IBS. Th e study was approved by the National Research Ethics Committee, United Kingdom (11/EM0245). Th is study was registered with the Clinicaltrials.gov (Identifi er NCT01534507). All subjects gave written informed consent and the study was carried out according to the Good Clinical Practice principles.
Subjects
Ninety-one subjects took part in the study. Th irty-four subjects were healthy volunteers (HV; 15 female, 19 male, 18-70 years) free from any history of gastrointestinal disease and surgery. Data for 21 of the 34 HV were obtained from a previous study ( 5 ) , which had similar MRI protocol and study design as current study but only the transit times have been published and these are now reported here. Fift y-seven subjects diagnosed by a doctor as having IBS were recruited from general gastroenterology clinics or via social media advertisements. Th e IBS group comprised of the following subtypes: 30 IBS with diarrhea (IBS-D) (18 female, male, 19-72 years), 16 IBS with constipation (IBS-C; 15 female, 1 male, 18-56 years) and 11 IBS with mixed bowel habit (IBS-M; 7 female, 4 male, 20-62 years). All these 57 subjects satisfi ed the Rome III criteria for IBS. A paper stool diary completed 7 days before the study was used to subtype their IBS based on stool form and frequency ( 6 ) (IBS-C=>25% type 1 or 2 and <25% type 6 or 7, IBS-M=>25% type 1 or 2 and >25% type 6 or 7, IBS-D=>25% type 6 or 7 and <25% type 1 or 2). Patients classifi ed as un-subtyped by stool diary were not included in the study. All subjects were required to stop any medications likely to aff ect bowel habit 14 days before the study, as well as avoid certain food known to aggravate IBS symptoms. All subjects completed a Hospital Anxiety and Depression (HAD) ( 7 ), Patient Healthy Questionnaire-12 Somatic Symptoms (PHQ12SS) ( 8 ) , Visceral sensitivity index (VSI) ( 9 ), IBS severity score (IBSSS) ( 10 ) and Perceived Stress Scale ( 11 ) questionnaires to assess psychological and severity of IBS symptoms. A MRI safety questionnaire was also completed to exclude contraindications to MRI.
Study design
Th e subjects swallowed 5 MRI marker capsules between 08:00-09:00 hours the day before the study day, to measure whole-gut transit time (WGTT) as previously described ( 5 ) . Th e subjects were reminded by telephone to swallow the 5 MRI marker capsules a day prior to the study day. Orocecal transit time (OCTT) was assessed using the Lactose-C13 Ureide breath test (LUBT) as previously described ( 5, 12 ) . Th e subjects were asked to ingest 1 g (6 mmol) of unlabeled lactose ureide (Euriso-top, St Aubin Cedex, France) three times during the day preceding the scans along with meals (morning, aft ernoon, and evening), to stimulate bacterial enzyme activity to cleave the lactose ureide in the colon. Th e following day, the subjects had a baseline MRI scan and provided a breath sample before consuming a 362 kcal breakfast which consisted of 220 g creamed rice pudding (J Sainsbury plc, London, UK) mixed with 34 g strawberry jam (J Sainsbury plc), 15 g course wheat bran (Holland and Barrett, Hinkley, UK) and 500 mg C 13 labeled Lactose Ureide along with100 ml orange juice (J Sainsbury plc). Following this, the subjects were scanned every 45 min for 7.5 h. Subjected were required to provide a breath sample every 10 min for the fi rst hour and then every 15 min for the next 7 h to assess OCTT. Approximately 6 h aft er breakfast, the subjects were fed a mixed nutrient meal consisting of 600 ml of Fortisip drink (Nutricia, Trowbridge, UK; Figure 1 ). All subjects completed questionnaires scoring abdominal symptoms (fullness, bloating, distension, abdominal pain and nausea) on a 0-10 cm visual analogue scale (VAS) scale immediately following each MRI scan to correlate these symptoms with the MRI fi ndings.
MRI protocol . MRI was carried out using a 1.5T Philips Achieva scanner (Philips Medical System, Best, Th e Netherlands). Subjects were scanned in the supine position using a 16-channel XL torso coil. Various imaging sequences were acquired to measure the following parameters: SBWC, AC water content, colonic volumes, colonic gas, and WGTT. A single-shot turbo-spin echo sequence (TR/TE=8000/320 ms, FA=90 0 , fi eld of view=400×362×168 mm 3 , acquired resolution=1.56×2.9×7.0 mm 3 ) was used to acquire T2 weighted coronal images of the abdomen for measurement of SBWC, as previously validated ( 13 ) . A dual echo fast fi eld echo sequence (TR/TE 1 /TE 2 =157/2.3/4.6 ms, FA=80 0 , FOV=450×362×168 mm 3 , acquired resolution=2.01×2.87×7 mm 3 ), acquiring 24 coronal slices, was used to measure colonic volumes ( 3 ) and colonic gas ( 14 ) . For assessment of WGTT, coronal scans were obtained at two stations with a 30 mm overlap using a multi-echo FFE sequence (TE 1 =1.41 ms, TE 2 =2.5 ms, TR=3.8 ms, FA=10 0 , FOV=250×371×200 mm 3 , AQR 1.8×1.8×3.6 mm 3 , SENSE factor=2). Th is sequence was used to create a maximum intensity projection image from water only reconstructed images, which allowed for three-dimensional visualization of the marker capsules as previously reported ( 5 ) .
Each image set was acquired on an expiration breath-hold for up to 25 s, depending on the sequence. Subjects spent ~15 min inside the magnet per time point, and sat in an upright position in the waiting room between each scan.
Data analysis
Measurements of colonic volumes were carried out by manually tracing around regions of interest (ascending, transverse, and descending colon) using Analyze9 soft ware (Biomedical Imaging Resource, Mayo Foundation, Rochester, MN, USA). Th e soft ware created three-dimensional object maps and summed volumes across all slices ( 3 ). Colonic gas was determined using these Analyze9 object maps using in-house soft ware written in IDL (IDL 6.4, Research Systems, Boulder, CO, USA) ( 15 ). Colonic gas was qualitatively identifi ed as regions that were completely black on the sum of the dual echo images. Th e distribution of noise in both echoes from the dual echo coronal images was determined by drawing regions of interest in the gas regions visible on the images. If no gas regions were visible the noise was determined from gas in the stomach or from noise regions outside the body. Th e colonic gas volume was then calculated as the voxel size multiplied by the number of voxels which were within the noise on both dual echo images (assessed for each echo separately) and which were located within the regions defi ned by the colonic volumes. An in-house program was used to measure SBWC using a previously validated method ( 13 ) . Measurement of WGTT was determined by scoring the position of the 5 marker capsules 24 h aft er ingestion and using a previously validated algorithm to determine a WGT time in hours ( 5 ) . Breath test samples were analyzed using an IRIS-Lab analyser machine (Wagner Analysen Technik, Bremen, Germany). Th e OCTT was taken as the time at which there is a rise in breath C 13 which is 2.5 times the s.d. of all previous points, as defi ned in a previous validation study ( 5, 12 ) .
Power and statistical analysis
Th e primary end point of this study was to compare the fasting SBWC in three subtypes of IBS, compared with healthy subjects. Secondary endpoints include OCTT in three subgroups of IBS, area under the curve (AUC) post-prandial SBWC, colonic volumes both fasting and postprandial, WGTT and correlation between HAD and OCTT and WGTT.
Statistical analysis was carried out with the use of GraphPad Prism version 6.0 for Windows (GraphPad Soft ware Inc, San Diego, CA, USA). Normality of the data was tested by using the D'Agostino and Pearson omnibus normality test. Normally distributed data are expressed as mean±s.d. and non-normally distributed data are expressed as median (interquartile range; IQR). Normally distributed data were analyzed using the unpaired t -test, one-way analysis of variance and two-way analysis of variance. Post hoc assessments were performed by using Bonferroni's multiple comparison test. Non-normally distributed data were analyzed using Mann-Whitney test and Kruskal-Wallis test. Post hoc assessments were performed by using Dunn's multiple comparison test. In the post hoc assessments, result were considered signifi cant if P ≤0.03, thus accounting for the eff ect of multiple comparisons.
Th e sample size for the IBS-M group was very small ( n =11). Th eir baseline demographics were listed in Table 1 . As the bowel frequency for IBS-M were similar to IBS-D, we have grouped IBS-M and IBS-D together and labeled as 'non-constipated IBS' (IBS-nonC) in subsequent analysis.
Sample size . Our previous study indicates the fasting SBWC in IBS-D was 50.6 (33.3) ml (mean (s.d.)), n =26 compared with normal values of 90.9 (67.7) ml, n =18 (pooled variance 1740) ( 2 ). Using n =30 in each group will give us a 90% power ( α =0.05) to detect a mean diff erence 20.3 ml from HV, a diff erence which is around half that previously observed in IBS-D. Although we achieved our target for IBS-D we under-recruited for the other subtypes and so combined these two groups for analysis of the MRI parameters.
We had no MRI data on WGT when the study was set-up but previous work from the Mayo Clinic using geometric centre of isotope markers suggests that n =14 would be suffi cient to detect clinically relevant eff ect sizes in the position of a group of markers in the colon at 24 or 48 h respectively ( 16 ) . IBS-D predominated in the patients recruited from our clinics so in the event we overrecruited this subgroup but found IBS-M surprisingly infrequent and so under-recruited this subgroup.
RESULTS

Demographics
Th e IBS patients in this study as expected were predominately female and were signifi cantly more anxious with high IBSSS and VSI scores compared with HV. Th ey also had signifi cantly more non-gastrointestinal, somatic symptoms with high PHQSS12 scores of 6 (4-9) when compared with HV of 2 (0-3), P <0.01 ( Table 1 ) . IBS patients had signifi cantly more abdominal symptoms such as abdominal pain, urgency and bloating than HV ( Table 1 ) . As expected subdividing patients according to their stool diaries created groups with the predicted diff erences in bowel frequency and stool consistency. Both IBS-D and IBS-M had greater stool frequency and Bristol Stool form score than IBS-C. IBS-D had signifi cantly more urgency than IBS-C.
MRI results
Small bowel water content . Fasting SBWC in IBS-nonC was signifi cantly less than HV and IBS-C ( P =0.03 and P <0.01 
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Regional Intestinal Volumes in IBS respectively; Table 2 and Figure 2a ) . As in previous studies the SBWC aft er our standard mixed solid/fl uid meal showed a biphasic response with an initial rapid fall from time 0-90 min followed by a sustained rise from 90 to 270 min ( Figure 2b ). Th e area AUC for post-prandial SBWC was assessed between the times aft er completing the test meal ( t =0 min) to the last MRI scans before lunch being provided ( t =360 min). Th e postprandial AUCs for SBWC were signifi cantly lower for IBS-nonC when compared with HV ( Table 2 and Figure 2c ) . IBS-C patients in contrast were no diff erent from the HVs in this respect.
Colonic volumes and gas . Fasting total colonic volumes in IBS-C were signifi cantly larger than IBS-nonC and HV ( Table 3 and Figure 3 ). Although fasting colonic segmental volumes (AC, TC and descending colon (DC)) were all numerically larger in IBS-C compared with HV only the TC volumes were signifi cantly so. Immediately aft er eating ( t =0 min), the AC volume showed a small rise in all but the IBS-D patients. Th is rise in AC volume was not signifi cantly diff erent between the 3 groups; P =0.15, Kruskal-Wallis. Following t =0 min, there were a decline in AC volume for all groups.
Postprandially, the TC volumes remained steady for the initial 3 h but then rose steadily over the subsequent 3 h. Th e TC colon was signifi cantly greater than baseline at the end of study ( t =405 min) for HV with mean diff erence 46 ml (standard error diff erence=22 ml), P =0.04. Th ere were no signifi cant changes in TC volumes at the end of study ( t =405 min) compared with baseline fasting TC ( t =−45 min) for the IBS-C (mean diff erence=3 ml (standard error diff erence=24 ml); P =0.9) and IBS-nonC (mean diff erence=9 ml (standard error diff erence=15 ml)).
Th e AUC for TC in IBS-C was strikingly and signifi cantly larger than HV and IBS-nonC and overall postprandial total colonic volume in IBS-C was also signifi cantly larger compared with IBSnonC ( Table 3 and Figure 4 ). Th e fasting total colonic gas in all 3 groups was similar and overall AUC postprandial total colonic gas ( t =0 to t =360 min) did not show signifi cant diff erence in the three groups ( Table 3 ) . between fasting SBWC with symptoms such as bloating, distension, fullness, pain, and nausea.
DISCUSSION
Objective assessments of the undisturbed small bowel and colonic regional volumes have not been previously possible. Using MRI we have been able to provide much unique data emphasizing the diff erences in small and large bowel volumes and motility in IBS subtypes. Our major fi nding was the striking increase in TC volumes in IBS-C compared with both healthy controls and IBS-nonC, both fasting and postprandially (see Supplementary  Figure S1 online). Th e TC may act as a buff er accommodating material from the AC and the descending colon whose volumes can change rapidly following a meal and defecation. Th us we have previously reported the normal initial rise in AC volume of 20-50 ml within 30 min aft er a meal as the gastro-ileal refl ex empties residue from the last meal into the colon before the arrival of the next meal. Th is rise is followed by a fall in the fi rst couple of hours aft er a meal. Th e opposite trend is seen with the descending colon whose volume falls immediately aft er a meal in healthy as well as IBS-nonC ( 3 ). Th is fall may refl ect retrograde movement from the sigmoid and left colon into the TC as has previously been reported postprandially ( 17 ) . Interestingly the postprandial changes in the descending colon did not seem as obvious with IBS-nonC compared with HV and IBS-C groups suggesting less retrograde movements which supports previous scintigraphic work ( 18 ) . Th us the fall in both AC and descending colon volumes seen in IBS-C resulted in a more prolonged rise in TC volumes, which accommodates this extra load. Th e TC shape is highly Orocecal transit test using LUBT . Th e OCTT for HV and IBS subtypes are shown in Table 4 . Even though IBS-D subtype had numerically lower OCTT, this was not statistically signifi cant.
WGTT . Th e WGTT using the MRI marker capsules showed the expected wide variability in IBS subtypes compared with HV ( Table 4 and Figure 5 ). Th e WGTT for IBS-C was signifi cantly longer than HV. Th e WGTT for IBS-nonC was not diff erent from HV.
Clinical symptoms
Correlations between anxiety, whole-gut transit and OCTTs . Th ere was no correlation between anxiety and OCTT in IBS patients overall (Spearman r =− 0.18, P =0.1). Subgroup analysis showed this was only signifi cant in the IBS-nonC patients ( Table 5 ). Th ere was a signifi cant correlation between anxiety and WGTT in the IBS-C group whereas the other 2 IBS groups showed no correlation ( Table 5 ) .
Correlations between clinical symptoms of bloating, distension, fullness, pain, and nausea, and segmented colonic volumes at t =405 min . Th ere was weak but signifi cant correlation between bloating score (VAS 0-10 cm) and TC volume following lunch at time t =405 min; Spearman r =0.21, P =0.04 ( Figure 6 ). Th e bloating score was higher in IBS-C following lunch, at time t =405 min, being 6 (3.2-9.3) while for other IBS subtypes it was 3.7 (1.1-7.4) cm, however owing to wide variability this just failed to reach statistical signifi cance P =0.06. Th ere were weak correlations between distension, pain and nausea with TC volume at time t =405 min, however, none of these achieved statistical signifi cance aft er correction for mulitple comparisons. Th ere were no correlations 
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variable and can extend down into the pelvis allowing it to increase its volume making it well designed to perform as a variable storage area.
Bloating is a very common sensation but poorly understood. Some individuals physically distend and although the sensation of bloating can come on at any time abdominal distension it would be gas in the TC that caused a larger TC volume but this was not so. Th e total gas volume detectable with our technique in the TC at t =405 min amounted to only 13 (1-50) ml in generally increases over the day ( 19 ) . Th e sensation of bloating showed similar biphasic response to meals which increased aft er breakfast ( t =0 min) and then slowly declined with a second peak immediately aft er eating the second meal at t =405 min. Th e bloating score and the TC volume following lunch ( t =405 min) showed a signifi cant correlation between each other. Our IBS-C patients had a higher bloating VAS score than other IBS subtypes as others have found ( 19 ) . Bloating correlated better with distension of the TC than AC, suggesting that the TC is more sensitive than the AC in keeping with a general gradient of increasing sensitivity as one moves distally in the gut. We had predicted that 
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IBS-C with similarly small amount of colonic gas in HV, IBS-D and IBS-M giving values of 17 (2-33), 10 (1-45) and 2 (0-5) ml respectively, P =0.11). Unexpectedly the AUC of the postprandial total colonic gas in HV was larger than in the IBS subtypes yet these volumes in HV do not correlate with bloating symptom (Spearman r =−0.2, P =0.32). Th e median peak bloating VAS score was minimal at 1.4 cm for the HV during the study. Th is insensitivity to distension in HV supports our previous fi ndings that even quite marked distension of the AC following ingestion of an osmotic laxative, produced virtually no abdominal symptoms in HV ( 20 ) presumably because there is receptive relaxation of the colonic muscle and hence no rise in wall tension which is what drives symptoms in both stomach ( 21 ) and rectum ( 21, 22 ) . Th is may explain why smooth muscle relaxants improve IBS symptoms in some patients ( 23 ) .
Th e fasting SBWC for IBS-nonC was signifi cantly smaller than HV, a fi nding consistent with our previous study in a separate IBS-D cohort ( 2 ) . Th e IBS-M group had similar results as the IBS-D group probably because they were in their 'diarrheal' phase around the study day since their baseline average stool frequency during the study period was similar to the IBS-D group ( Table 1 ) . Th e smaller fasting SBWC values in IBS-nonC distinguish them from both healthy controls and IBS-C. Our previous study had observed narrowed small bowel in IBS-D patients which we called the 'spaghetti bowel' . Th is correlated inversely with anxiety and this may refl ect increased muscular tone in small bowel rather than accelerated transit ( 2 ). We were able to reproduce this feature in HVs using an injection of the stress hormone Corticotrophin Releasing Factor ( 24 ) suggesting this might be a stress response in susceptible subjects.
We used the LUBT method to measure OCTT which has been shown to correlate with scintigraphic assessment with a slight overestimate ( 12 ) . We found no correlation between fasting SBWC and OCTT nor between OCTT and postprandial AUC SBWC.
Th e OCTT and WGTT for IBS subtypes show a range of values for all subgroups mostly within the wide normal ranges for OCTT. Th is is the fi rst study using MRI as a tool to give us a better insight into diff erent gastrointestinal physiology of IBS patients. One of our aims was to determine whether colonic volumes and SBWC could be better biomarkers for IBS subtypes than symptoms alone. Using the fasting TC volume there was quite an overlap between the constipated and non-constipated IBS. However, using a cut-off for the TC volume of 300 ml, only 31% IBS-C meet this criteria but specifi city would be 95%. Th is defi nes a distinct subgroup which have a signifi cantly enlarged TC. Whether such individuals respond diff erently to treatments is something we aim to evaluate in future studies.
In conclusion, this observational study shows some novel insights into the gastrointestinal physiology of IBS. MRI has proven to be a useful tool to assess small and large bowel as it is patient acceptable and easily repeatable. Our fi ndings will hopefully stimulate many new questions, in particular what eff ect commonly used drugs like antispasmodics and laxatives have in the gastrointestinal tract of IBS patients. Th ese are all questions that MRI is well placed to answer. Th ese future studies should also examine the response to treatments to determine how well colonic volumes explain the associated change in symptoms such as bloating and abdominal discomfort.
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Th e WGTT in IBS-C as others have found ( 25, 26 ) was signifi cantly greater than HV whereas the WGTT in IBS-nonC was similar to HV ( P =0.60). Th e fast WGTT (median (IQR)= 34 (19-81) h) in IBS-M is in keeping with their increased average bowel frequency compared to HV ( Table 1 ).
Limitations
Although we were adequately powered for the IBS-D group the numbers in IBS-C and IBS-M groups were lower than planned. Th e clinical and MRI features for IBS-M were similar, therefore they were grouped together with IBS-D. One problem with IBS-M is knowing when to study them. It seems likely that the MRI features we described would be diff erent during diff erent phases of their condition. Perhaps it is their variability, which is the key feature, which means they need to be studied on at least 2 occasions to capture this aspect. It should be recognized that the method used for WGTT has only been validated against the gold standard radio-opaque method for values in the range 0-80 h. Th us while we can be confi dent in the values for most of the patients in the present study we can be less certain about the few with WGTT over 80 h although we can be confi dent they are >80 h. We, using nonparametric statistics, which do not rely on a linear scale to assess the fi ndings that IBS-C, have prolonged transit so we feel confi dent that these limitations have not invalidated our conclusions. Th e typical wide variability both inter-individual and intra-individual in both our and others studies likely refl ect true variability induced by daily diff erences in diet, emotions and defecatory timings in both patients and HV which are not usually controlled as was true in our study.
We have not adjusted the P values for the multiple comparisons shown in Table 3 . Although this risks increasing the Type 1 error rate the diff erences we have observed are not random but all fi t the same pattern, namely that IBS-C have slower transit and larger colons so we believe a Bonferroni correction would be over conservative. However we do accept that our fi ndings need confi rmation in a separate cohort.
Th e typical wide variability both inter-individual and intraindividual in both our and others studies likely refl ect true variability induced by daily diff erences in diet, emotions and defecatory timings in both patients and HV which are not usually controlled as was true in our study. Another limitation was the lack of recording of bowel symptoms during the study period. Th e bowel movements for each participant may vary with each IBS subtypes and thus aff ect its colonic volumes throughout the day however we found the postprandial AUC for the total colonic volumes between HV, IBS-D, and IBS-M were similar and did not show the abrupt fall in volume we would have anticipated had defaecation occurred.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ There is a lack of biomarkers which objectively subgroup irritable bowel syndrome (IBS). ✓ IBS-C subtype shows delayed transit associated with an enlarged TC both fasting and postprandially.
